Veterinary medicines

Ivomec-P 18,7 mg/g Paste zum Eingeben für Pferde

Recall | Veterinary Medicines | 18/07/2023
Recall due to temperature exceedance during transport
Ivomec-P 18,7 mg/g Paste zum Eingeben für Pferde Read more

Semintra 10 mg/ml Lösung zum Eingeben für Katzen

Recall | Veterinary Medicines | 10/07/2023
Recall due to an undercutting of the pH value and formation of a precipitate
Semintra 10 mg/ml Lösung zum Eingeben für Katzen Read more

Bupaq 0,3 mg/ml Injektionslösung für Hunde und Katzen

Recall | Veterinary Medicines | 05/07/2023
Recall due to possible reduced active ingredient content
Bupaq 0,3 mg/ml Injektionslösung für Hunde und Katzen Read more

Clavudale 40 mg/10 mg Tabletten für Katzen und Hunde

Recall | Veterinary Medicines | 14/04/2023
Recall due to out of specification results
Clavudale 40 mg/10 mg Tabletten für Katzen und Hunde Read more

Information about the new withdrawal period of Toltrazuril

Safety warnings | Veterinary Medicines | 31/01/2023
Important information from the Federal Office for Public Health Safety on the new withdrawal period for veterinary medicinal products containing Toltrazuril for oral administration to chickens.
Information about the new withdrawal period of Toltrazuril Read more

Nerfasin vet. 20 mg/ml - Injektionslösung für Rinder, Pferde, Hunde und Katzen

Recall | Veterinary Medicines | 14/07/2022
Recall due to visible particles in solution for injection in retention samples
Nerfasin vet. 20 mg/ml - Injektionslösung für Rinder, Pferde, Hunde und Katzen Read more
News

Information on possible side effects in animals after contact with hormone-containing medicinal products when applied to the skin of humans

| 25/04/2022
Following reports of adverse effects in animals, BASG draws attention to the fact that precautions should be taken to avoid contact of pets with hormone-containing drugs used on the skin of humans.
Information on possible side effects in animals after contact with hormone-containing medicinal products when applied to the skin of humans Read more
Email

Further inquiry note